A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...
In a first-in-human phase 1/2a clinical trial, researchers used adult stem cells to help restore vision in people with age-related macular degeneration. In the United States, age-related macular degen ...
Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...
As many as 15 million people in the United States have some form of age-related macular degeneration, a leading cause of vision loss among people 50 and older. Nine out of 10 of them have the dry form ...
Aalto University scientists have created a laser-based treatment that uses gentle heat to stop the progression of dry macular ...
ANNX advances tanruprubart for Guillain-Barré syndrome, with an EMA filing planned for January 2026 and ongoing FDA ...
The overall dry AMD market size in the US is anticipated to increase, due to the uptake of recently approved therapies, the launch of emerging therapies such as Gildeuretinol (Alkeus Pharmaceuticals), ...
Support local journalism. A digital subscription is incredibly affordable and makes you the most informed person around. Click here and subscribe today Many frightening thoughts may go through your ...
This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye, and it marks the second of a three-part series on dry ...
In a study published in Cell Stem Cell, scientists tested retinal pigment epithelial stem cells in a phase 1/2a clinical trial. The cells were obtained from adult postmortem eye tissue. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback